Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Roche’s ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
MS Research Roundup: November 21, 2014
Histologie de la sclerose en plaques
Autoimmunity's next top models.
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Foreseeing the Future?
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
MS Research Roundup: January 9, 2014
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica: Multicenter Study of Treatment Efficacy.
MS Patient, Ph.D.: Setting the Right Expectations for Recovery
Low testosterone is associated with disability in men with multiple sclerosis.
Support MSDF
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
ISN-APSN Biennial Meeting
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.
National MS Society: Pilot Research Grants
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses.

Pages